It is not known how underlying subclinical papillary thyroid cancer (PTC) differs by age. This meta-analysis of autopsy studies investigates how subclinical PTC prevalence changes over the lifetime.
Recalibrating diagnostic thresholds or using alternative labels may mitigate overdiagnosis and overtreatment of microscopic papillary thyroid cancer (mPTC). We aimed to identify and collate relevant epidemiological evidence on mPTC, to assess the case for recalibration and/or new labels.
Thyroid cancer is more common in women than in men, but the associated causes of these differences are not fully understood. This study aimed to compare sex-specific thyroid cancer rates in the US to the prevalence of subclinical thyroid cancer at autopsy.
During the COVID-19 pandemic, patients with lower risk thyroid cancer may have had to ‘sit’ with knowledge of their cancer for a prolonged period of time while awaiting surgery. For patients with higher risk cancers, surgical treatments including completion thyroidectomy, radioactive iodine therapy and use [...]
It is a rare study that successfully combines 3 different methods and data sets to address a research question. The study by Davies et al in this issue of JAMA Otolaryngology–Head & Neck Surgery examines the model of care offered to patients in Japan for papillary thyroid cancer. [...]
This stufy found a strong and apparently widely held desire for more information surrounding the topic of overdiagnosis and overtreatment. Careful consideration of how to inform both the public and current patients about the implications of a change in terminology, including changes to patients’ follow-up [...]
What health-related quality of life outcomes are associated with diagnosis and treatment of differentiated thyroid cancer and do they vary by type of surgery received? In this content analysis of survey responses of 1005 patients with differentiated thyroid cancer, 775 (77.1%) reported issues in their [...]
